A detailed history of Nixon Peabody Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Nixon Peabody Trust CO holds 1,300 shares of AMGN stock, worth $410,800. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,300
Previous 1,500 13.33%
Holding current value
$410,800
Previous $426,000 4.69%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$262.75 - $319.31 $52,550 - $63,862
-200 Reduced 13.33%
1,300 $406,000
Q1 2024

May 07, 2024

SELL
$268.87 - $324.56 $13,981 - $16,877
-52 Reduced 3.35%
1,500 $426,000
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $396,846 - $447,689
1,552 New
1,552 $447,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Nixon Peabody Trust CO Portfolio

Follow Nixon Peabody Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nixon Peabody Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Nixon Peabody Trust CO with notifications on news.